PRCTPROCEPT BioRobotics Corporation

$21.07

The financials

PROCEPT BioRobotics Corporation by the numbers

PROCEPT BioRobotics Corporation (PRCT) reported revenue of $83M in Q1 2026 (quarter ended March 31, 2026), up 20% from the same quarter a year earlier. That came with a gross margin of 65% and net loss of $32M. For the full year FY2025, revenue was $308M (+37% year on year) and net income −$96M. Its largest product in 2026-Q2 was Hand Pieces And Other Consumables at $48M, 58% of the disclosed total, just ahead of System Sales And Leases at 35%.

PROCEPT BioRobotics Corporation income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$83M$69M+20%
Gross profit$54M$44M+22%
Operating income−$33M−$27Mn/a
Net income−$32M−$25Mn/a
Diluted EPS−$0.56−$0.45n/a
Revenue by product, 2026-Q2, as reported to the SEC
ProductRevenueShare
Hand Pieces And Other Consumables$48M58%
System Sales And Leases$29M35%
Service$6.0M7.2%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q2 2026Total $83.4M (+16%)
Service grew +37% year on yearHand Pieces And Other Consumables +12% year on year
  • Hand Pieces And Other Consumables$48.4MQoQ +12%year on year +12%
  • System Sales And Leases$29.1MQoQ -year on year +32%
  • Service$6.0MQoQ +6.6%year on year +37%
  • System Sales And Rentals-QoQ -year on year -
Segment sum = 88% of reported consolidated revenue (partial disaggregation) · Latest source: 10-Q filed 2026-08-05, SEC EDGAR